Abbott Laboratories final week filed a federal lawsuit in opposition to Jerome Clavel, whom Abbott described as vp of worldwide advertising and marketing in its diagnostics enterprise, claiming he’s “about to take its worthwhile plans and commerce secrets and techniques to its direct competitor, Bio-Rad Laboratories, Inc.”
The lawsuit in Northern District of U.S. District Court docket within the Northern District of Illinois the place Abbott’s headquarters are positioned states that Clavel labored within the space primarily liable for Abbott’s fast diagnostics COVID testing. It states he resigned from Abbott on October 15 “telling his boss and a Human Assets consultant that he was doing so for his well being and well-being.” The lawsuit stated that whereas Clavel stated he had not “signed on with any job at this level,” he had truly signed a proposal letter accepting the job of vp of selling Bio-Rad’s Medical Diagnostics division on October 15, “the exact same day he resigned.”
The swimsuit says that Clavel had entry to Abbott’s confidential and commerce secret details about its present and future enterprise plans. “Clavel knew that going to Bio-Rad’s Medical Diagnostics division could be a breach of his Employment Settlement with Abbott, which prohibits him from working in an identical perform for a competing enterprise for twelve months after leaving his employment,” the lawsuit says. The lawsuit accuses Clavel of mendacity about signing with Bio-Rad on quite a few events.
The lawsuit seeks an order stopping Clavel from assuming any place at Bio-Rad and from disclosing Abbott commerce secrets and techniques or proprietary data.
This story first appeared in our sister publication, Crain’s Chicago Enterprise.